Report Highlights
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Report Includes
- 220 data tables and 59 additional tables
- An analysis of the global markets for single-use technologies for biopharmaceutical manufacturing
- Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the size and revenue prospects of the global market, along with a market share analysis by technology, single-use component, application, end user, and region/country
- A look at recent technical advances in different sole-use technologies and bioreactors and the extent of adoption by commercial customers and regulatory authorities
- Facts and figures pertaining to the market dynamics, technical advances, regulations, and the impact of region- and industry-specific macroeconomic variables
- A Porter’s Five Forces model, and global supply chain and PESTLE analyses
- Patent activity and key patent grants/publications, along with an analysis of the impact of new developments in sole-use technologies and bioreactors for pharmaceuticals
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
- Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and a venture funding outlook
- Profiles of market leaders, including Danaher Corp, Thermo Fisher Scientific Inc., Sartorius AG and Merck KGaA.
Report Scope
This report summarizes the single-use technologies market, including a market snapshot and company profiles of key players. It provides a comprehensive market breakdown with in-depth information regarding each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges and opportunities for the market. It provides information on emerging technologies and developments in the industry. It analyzes critical market players’ financials, product portfolios and recent activities.
BCC Research analyzed and made projections of each market and its applications, along with forecasts for the next five years. The report also features profiles of leading companies in the biopharmaceutical single-use technologies industry, including Sartorius AG, Danaher Corp, Merck KGaA and Thermo Fisher Scientific Inc.
The market is segmented by geographical region into North America, Europe, Asia-Pacific and the Rest of the World (RoW). Regional analysis is further broken down by country as:
- North America: The U.S., Canada and Mexico.
- Europe: Germany, the U.K., France, Italy, Spain and the Rest of Europe.
- Asia-Pacific: China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific.
Data for market estimates have been provided for 2021 and 2022 as the historical years, 2023 as the base year and forecast through 2029.
Report Synopsis
| Report Metrics | Details | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||
| Base year market size | $5.8 billion | ||||||||||||||
| Market size forecast | $11.2 billion | ||||||||||||||
| Growth rate | CAGR of 11.6% for the forecast period of 2024-2029 | ||||||||||||||
| Units considered | $ Millions | ||||||||||||||
| Segments covered | Technology, Component, Application, End User, and Region | ||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America, Middle East and Africa | ||||||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, France, U.K., Spain, Italy, China, India, Japan, South Korea, and Australia | ||||||||||||||
| Key Market Drivers |
|
||||||||||||||
| Companies studied |
|
||||||||||||||
Frequently Asked Questions (FAQs)
- Sartorius AG
- Danaher Corp.
- Merck KGaA
- Thermo Fischer Scientific Inc.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for single-use technologies in biopharmaceutical manufacturing should grow from $4.3 billion in 2021 to $7.3 billion by 2026 with a compound annual growth rate (CAGR) of 11.3% for the period of 2021-2026.
Report Includes
- 208 data tables and 22 additional tables
- An overview of the global market for single-use technologies for the biopharmaceutical industry
- Estimation of the market size and analyses of global market trends, with data from 2018-2021, with projections of compound annual growth rates (CAGRs) through 2026
- Discussion on present and future opportunities and key factors influencing the single-use technologies and bioreactors for pharmaceuticals
- Quantification of market applications, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and anticancer drugs
- Highlights of the market potential for single-use technologies for the biopharmaceutical industry, based on technology, component, application, end user, and region
- Description of biologics manufacturing process including upstream and downstream processing and cell harvesting and clarification, and information on single-use technology (SUT)
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast, and assessment of new developments in the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Company profiles of major players, including Merck KGaA, Thermo Fisher Scientific Inc., General Electric Co., Danaher Corp., and Sartorius AG
Report Highlights
The global single-use technology in the biopharmaceutical market should reach $5.9 billion by 2024 from $3.5 billion in 2019 at a compound annual growth rate (CAGR) of 11.3% for the period of 2019 to 2024.
Report Includes
- 58 data tables and 18 additional tables
- An overview of the global market for single-use technologies for the biopharmaceutical industry
- Analyses of global market trends, with data from 2018, estimates for 2019 and projections of CAGRs through 2024
- Discussion on present and future opportunities and key factors influencing the single-use technologies and bioreactors for pharmaceuticals
- Quantification of market applications, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and anticancer drugs
- Impact analysis on pharmaceutical, biotechnology and healthcare sectors
- Coverage of new product developments and technologies, mergers & acquisitions, partnership & collaboration and new product launches in the industry
- Profiles of major players in the industry, including Aber Instruments Ltd., Corning Inc., General Electric Co., Parker Hannifin Corp., Repligen Corp., Sartorius AG, and Thermo Fisher Scientific Inc.
Report Highlights
The global market for single-use technology reached $2.7 billion in 2016. The market should reach over $4.3 billion by 2021, growing at a compound annual growth rate (CAGR) of 10.1% from 2016 to 2021.
Report Includes
- An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters.
- Analyses of global market trends, with data from 2014, 2015 and 2016, and projections of CAGRs through 2021.
- In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges.
- Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs.
- Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares.
- Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns.
- Relevant patent analysis.
Report Highlights
The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.
Report Includes
- An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters.
- Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
- In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges.
- Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs.
- Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares.
- Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns.
- Relevant patent analysis.
Report Highlights
The global market for single-use technologies for biopharmaceuticals was valued at $720 million in 2011 and should reach $985.2 million in 2012. Total market value is expected to reach nearly $2.4 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 19.1%.
Report Includes
- An overview of biopharmaceutical single-use technologies, which aids the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges
- Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs
- Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares
- Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns
- Comprehensive company profiles of existing and potential market players
- Patent analysis.
Related Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Pharmaceutical Filtration: Global Markets
The global market for pharmaceutical filtration was valued at $10.4 billion in 2023. The market is estimated to grow from $11.4 billion in 2024 to $18.1 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2029.
3D Cell Cultures: Technologies and Global Markets
The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More